Hi Harvett, it could have a connection to the ESMO data presentation this weekend, as mentioned in Kazia September 2019 Investors Newsletter.
"Meanwhile, the Cantrixil phase I study has been progressing extremely well and is now close to completion, with completion expected in the first half of next year. New data will be reported at the upcoming ESMO conference in late September, and this should help to provide further insight into the potential efficacy of Cantrixil."
Regards.
- Forums
- ASX - By Stock
- Cantrixil Study
Hi Harvett, it could have a connection to the ESMO data...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online